Skip to main content
Clinical Trials/CTRI/2023/07/055286
CTRI/2023/07/055286
Not yet recruiting
未知

Correlation of Plasma Oxidative stress markers with the Severity of Melasma - nil

FATHER MULLER RESEARCH CENTRE0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: L811- Chloasma
Sponsor
FATHER MULLER RESEARCH CENTRE
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients of age 18years and above.
  • 2\.Patients of all gender.
  • 3\.Patients diagnosed with melasma clinically with MASI score indicating severity.

Exclusion Criteria

  • 1\.Patients who are pregnant, active smokers, on hormonal therapy, consumption of antioxidant supplements.
  • 2\.Patients with vitiligo, psoriasis, facial melanosis excluding melasma, other causes of skin pigmentation like acanthosis nigricans, sun tan, hair dye etc
  • 3\.Patients with endocrine and chronic systemic diseases like diabetes mellitus, heart failure, systemic lupus, etc.
  • 4\.Patients on drugs affecting antioxidant levels like hydroxychloroquine,immunosuppresive drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials